Prestige Consumer Healthcare (PBH) Total Non-Current Liabilities (2013 - 2025)

Prestige Consumer Healthcare (PBH) recorded quarterly Total Non-Current Liabilities of $1.7 billion in Q4 2025, up 2.95% quarter-over-quarter from $1.6 billion in Q3 2025, and up 8.04% on a YoY basis from $1.5 billion in Q4 2024.

Prestige Consumer Healthcare (PBH) Total Non-Current Liabilities (2013 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Total Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $1.7 billion for Q4 2025.

  • In Q4 2025, Total Non-Current Liabilities rose 8.04% year-over-year to $1.7 billion; the TTM figure through Dec 2025 stood at $1.7 billion (up 8.04% YoY), while the FY2025 annual figure was $1.6 billion, down 5.57% from the prior year.
  • Total Non-Current Liabilities was $1.7 billion for Q4 2025 at Prestige Consumer Healthcare, up from $1.6 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $2.2 billion in Q3 2021 to a low of $1.5 billion in Q4 2024.
  • Historically, Total Non-Current Liabilities has averaged $1.8 billion across 5 years, with a median of $1.8 billion in 2023.
  • The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities declined 15.76% in 2023, then gained 8.04% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $2.1 billion in 2021, then slipped by 3.69% to $2.1 billion in 2022, then slipped by 15.76% to $1.7 billion in 2023, then dropped by 11.23% to $1.5 billion in 2024, then rose by 8.04% to $1.7 billion in 2025.
  • The last three Total Non-Current Liabilities figures came in at $1.7 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.6 billion (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 Prestige Consumer Healthcare 2.37 Bn 2.31 Bn 157.37 Mn 1.66 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.66 Bn
Sep 30, 2025 1.61 Bn
Jun 30, 2025 1.57 Bn
Mar 31, 2025 1.56 Bn
Dec 31, 2024 1.54 Bn
Sep 30, 2024 1.58 Bn
Jun 30, 2024 1.62 Bn
Mar 31, 2024 1.65 Bn
Dec 31, 2023 1.73 Bn
Sep 30, 2023 1.79 Bn
Jun 30, 2023 1.86 Bn
Mar 31, 2023 1.90 Bn
Dec 31, 2022 2.05 Bn
Sep 30, 2022 2.05 Bn
Jun 30, 2022 2.09 Bn
Mar 31, 2022 2.09 Bn
Dec 31, 2021 2.13 Bn
Sep 30, 2021 2.21 Bn
Jun 30, 2021 2.13 Bn
Mar 31, 2021 2.06 Bn